[go: up one dir, main page]

GB202103563D0 - Treatment for autoimmune diseases - Google Patents

Treatment for autoimmune diseases

Info

Publication number
GB202103563D0
GB202103563D0 GBGB2103563.9A GB202103563A GB202103563D0 GB 202103563 D0 GB202103563 D0 GB 202103563D0 GB 202103563 A GB202103563 A GB 202103563A GB 202103563 D0 GB202103563 D0 GB 202103563D0
Authority
GB
United Kingdom
Prior art keywords
treatment
autoimmune diseases
autoimmune
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2103563.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LDN Pharma Ltd
Original Assignee
LDN Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LDN Pharma Ltd filed Critical LDN Pharma Ltd
Priority to GBGB2103563.9A priority Critical patent/GB202103563D0/en
Publication of GB202103563D0 publication Critical patent/GB202103563D0/en
Priority to PCT/GB2022/050650 priority patent/WO2022195263A1/en
Priority to GB2312427.4A priority patent/GB2619181A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2103563.9A 2021-03-15 2021-03-15 Treatment for autoimmune diseases Ceased GB202103563D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2103563.9A GB202103563D0 (en) 2021-03-15 2021-03-15 Treatment for autoimmune diseases
PCT/GB2022/050650 WO2022195263A1 (en) 2021-03-15 2022-03-14 Treatment for autoimmune disease
GB2312427.4A GB2619181A (en) 2021-03-15 2022-03-14 Treatment for autoimmune disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2103563.9A GB202103563D0 (en) 2021-03-15 2021-03-15 Treatment for autoimmune diseases

Publications (1)

Publication Number Publication Date
GB202103563D0 true GB202103563D0 (en) 2021-04-28

Family

ID=75623167

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB2103563.9A Ceased GB202103563D0 (en) 2021-03-15 2021-03-15 Treatment for autoimmune diseases
GB2312427.4A Pending GB2619181A (en) 2021-03-15 2022-03-14 Treatment for autoimmune disease

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2312427.4A Pending GB2619181A (en) 2021-03-15 2022-03-14 Treatment for autoimmune disease

Country Status (2)

Country Link
GB (2) GB202103563D0 (en)
WO (1) WO2022195263A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3482751A1 (en) * 2017-11-14 2019-05-15 LDN Pharma Limited Cancer treatment
GB201805207D0 (en) * 2018-03-29 2018-05-16 Ldn Pharma Ltd Autoimmune therapy
GB201903546D0 (en) * 2019-03-15 2019-05-01 Ldn Pharma Ltd Cancer treatment

Also Published As

Publication number Publication date
GB202312427D0 (en) 2023-09-27
GB2619181A (en) 2023-11-29
WO2022195263A1 (en) 2022-09-22

Similar Documents

Publication Publication Date Title
IL290980A (en) Rna for treatment of autoimmune diseases
SG11202006374VA (en) Treatment of demyelinating diseases
GB202109021D0 (en) Treatment for autoimmune diseases
PT3761982T (en) Treatment of demyelinating diseases
GB202108224D0 (en) Treatment
GB202103563D0 (en) Treatment for autoimmune diseases
GB202003644D0 (en) Treatment for autoimmune diseases
GB202116743D0 (en) Treatment
GB202103122D0 (en) Treatment
GB202018400D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB201903547D0 (en) Treatment for autoimmune diseases
GB201909438D0 (en) Treatment of diseases
GB202114373D0 (en) Treatment
GB202109815D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202102488D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202102369D0 (en) Treatment
GB202102373D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)